中国医药指南
中國醫藥指南
중국의약지남
CHINA MEDICINE GUIDE
2015年
1期
18-19
,共2页
下呼吸道感染%病原菌种类%耐药性
下呼吸道感染%病原菌種類%耐藥性
하호흡도감염%병원균충류%내약성
The lower respiratory tract infection%Pathogenic bacteria species%Drug resistance
目的：了解并掌握2013年我院临床下呼吸道感染病原菌种类及耐药性，指导临床合理用药。方法美国BD phoenix 100全自动细菌鉴定药敏检测系统数据库2013年数据并应用WHONET5.5细菌耐药监测软件进行回顾性统计分析。结果革兰阴性菌60.42%；革兰阳性菌9.98%；真菌29.60%。革兰阴性菌中肺炎克雷伯菌31.01%，大肠埃希菌13.62%，铜绿假单胞菌7.83%；革兰阳性菌中金黄色葡萄球菌54.39%，肺炎链球菌22.81%；真菌中白假丝酵母菌55.03%，热带假丝酵母菌31.95%。结论下呼吸道感染以革兰阴性菌为主60.42%，肺炎克雷伯菌检出率最高，其对阿莫西林/克拉维酸、哌拉西林、氨苄西林/舒巴坦呈现较高耐药。大肠埃希菌耐药严重，平均耐药率33.68%。革兰阳性菌感染以金黄色葡萄球菌为主，糖肽类、恶唑烷酮类仍是治疗革兰阳性菌感染最有效的药物。细菌合并真菌的二重感染不容忽视，加强耐药监测，指导临床合理用药。
目的：瞭解併掌握2013年我院臨床下呼吸道感染病原菌種類及耐藥性，指導臨床閤理用藥。方法美國BD phoenix 100全自動細菌鑒定藥敏檢測繫統數據庫2013年數據併應用WHONET5.5細菌耐藥鑑測軟件進行迴顧性統計分析。結果革蘭陰性菌60.42%；革蘭暘性菌9.98%；真菌29.60%。革蘭陰性菌中肺炎剋雷伯菌31.01%，大腸埃希菌13.62%，銅綠假單胞菌7.83%；革蘭暘性菌中金黃色葡萄毬菌54.39%，肺炎鏈毬菌22.81%；真菌中白假絲酵母菌55.03%，熱帶假絲酵母菌31.95%。結論下呼吸道感染以革蘭陰性菌為主60.42%，肺炎剋雷伯菌檢齣率最高，其對阿莫西林/剋拉維痠、哌拉西林、氨芐西林/舒巴坦呈現較高耐藥。大腸埃希菌耐藥嚴重，平均耐藥率33.68%。革蘭暘性菌感染以金黃色葡萄毬菌為主，糖肽類、噁唑烷酮類仍是治療革蘭暘性菌感染最有效的藥物。細菌閤併真菌的二重感染不容忽視，加彊耐藥鑑測，指導臨床閤理用藥。
목적：료해병장악2013년아원림상하호흡도감염병원균충류급내약성，지도림상합리용약。방법미국BD phoenix 100전자동세균감정약민검측계통수거고2013년수거병응용WHONET5.5세균내약감측연건진행회고성통계분석。결과혁란음성균60.42%；혁란양성균9.98%；진균29.60%。혁란음성균중폐염극뢰백균31.01%，대장애희균13.62%，동록가단포균7.83%；혁란양성균중금황색포도구균54.39%，폐염련구균22.81%；진균중백가사효모균55.03%，열대가사효모균31.95%。결론하호흡도감염이혁란음성균위주60.42%，폐염극뢰백균검출솔최고，기대아막서림/극랍유산、고랍서림、안변서림/서파탄정현교고내약。대장애희균내약엄중，평균내약솔33.68%。혁란양성균감염이금황색포도구균위주，당태류、악서완동류잉시치료혁란양성균감염최유효적약물。세균합병진균적이중감염불용홀시，가강내약감측，지도림상합리용약。
Objective To understand and grasp our hospital in 2013 clinical lower respiratory infection pathogenic bacteria species and drug resistance, to guide clinical rational drug use.Methods The BD phoenix 100 automatic bacteria identification application database data in 2013 and drug susceptibility testing system WHONET5.5 retrospective statistical analysis of bacterial drug resistance monitoring software.Results Gram-negative bacteria 60.42%;Gram-positive bacteria 9.98%; Fungi was 29.60%. Gram-negative bacteria klebsiella pneumoniae in 31.01%, 13.62% E. coli, pseudomonas aeruginosa 7.83%; Gram positive bacterium staphylococcus aureus 54.39%, streptococcus pneumoniae 22.81%; Fungi white candida yeast 55.03%, and 31.95% tropical candida.Conclusions The lower respiratory tract infection is given priority to with gram-negative bacteria 60.42%, klebsiella pneumoniae detection rate is highest, its to amoxicillin/clavulanic acid, piperacillin, ampicillin/shu ba present high drug resistance. E. coli resistance, resistance to an average of 33.68%. Gram-positive bacteria infection is given priority to with staphylococcus aureus, sugar peptide, pbo alkane ketone is still the most effective treatment of gram-positive bacteria infection. Bacteria merged fungi double infection should not be ignored, to strengthen the resistant monitoring and to guide clinical rational drug use.
